In vitro and in vivo viability assessment of unpurified pancreatic islet tissue. 1994

U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
Department of Surgery, University of Cologne, Germany.

The viability of porcine collagenase-prepared islet preparations (n = 16) was classified by 31P-NMR spectroscopy, staining by neutral red and trypan blue, and in vitro insulin secretion following glucose challenge. Vital islets exhibited a phosphate diester/phosphate monoester (PDE/PME) ratio of 0.5-0.9, a staining score of 18-30 and an insulin secretion responding well to glucose challenge. Damaged islets performed at a PDE/PME of 0.2-0.49 and a staining score of 9-17 and necrotic islets had 0.0-0.49 and a staining score of 9-17 and necrotic islets had 0.0-0.19 and 0-8, respectively. The islets of the latter two groups did not adequately respond to glucose. The in vivo function following autotransplantation of these islets into the spleen was investigated in five recipients of more than 3000/kg vital islets of which 4 expressed daily normoglycemia (< 200 mg%), normalized intravenous glucose tolerance (K = -2.21), and a prolonged survival (mean +/- SD) of 167 +/- 12 days compared to five recipients of > 3000/kg damaged islets (K = -0.814) (P = 0.0017) and a survival of 86 +/- 21 days (P = 0.0096). It is suggested that 31P-NMR spectroscopy is a valuable and practical method to predict islet graft viability prior to transplantation in order to assure good graft function in the recipient.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D009499 Neutral Red A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems. Toluylene Red,C.I. Basic Red 5,Nuclear Fast Red (Basic Dye),Red, Neutral,Red, Toluylene
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
June 1988, Diabetologia,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
September 2023, Cells,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
May 2000, Cell transplantation,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
January 2000, Cell transplantation,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
December 2001, Transplantation,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
October 2005, Transplantation proceedings,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
September 1968, Lakartidningen,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
January 2005, Current pharmaceutical design,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
April 2005, Transplantation,
U J Hesse, and M Schmitz-Rode, and J Danis, and B Tunggal, and G Meyer, and J Weyer, and H Pichlmaier
June 2022, Stem cells translational medicine,
Copied contents to your clipboard!